Gilead's Truvada May Cut HIV Infection Risk, FDA Says
Gilead Sciences Inc.'s Truvada, an antiretroviral drug widely used in HIV treatment, is effective at preventing HIV infection in at-risk individuals, according to a U.S. Food and Drug Administration report released...To view the full article, register now.
Already a subscriber? Click here to view full article